| Lianne Liang-jung Lin, MD | |
|
9427 Sw Barnes Rd Ste 296, Portland, OR 97225-6652 | |
| (503) 297-3778 | |
| (503) 297-7853 |
| Full Name | Lianne Liang-jung Lin |
|---|---|
| Gender | Female |
| Speciality | Pulmonary Disease |
| Experience | 16 Years |
| Location | 9427 Sw Barnes Rd Ste 296, Portland, Oregon |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497910210 | NPI | - | NPPES |
| 500639174 | Medicaid | OR | |
| 2014389 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0200X | Internal Medicine - Critical Care Medicine | MD155788 (Oregon) | Secondary |
| 207RP1001X | Internal Medicine - Pulmonary Disease | MD155788 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence St Vincent Medical Center | Portland, OR | Hospital |
| Providence Newberg Medical Center | Newberg, OR | Hospital |
| Legacy Meridian Park Medical Center | Tualatin, OR | Hospital |
| Providence Seaside Hospital | Seaside, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Oregon Clinic Pc | 2860390408 | 319 |
News Archive
Existing techniques for predicting premature birth are inadequate or invasive - with risks and discomfort. Researcher Chiara Rabotti (Eindhoven University of Technology) developed a new measuring method, based on a rather simple electrode plaster that is attached to the abdomen. In the future every pregnant woman can thereby calmly await the moment, Rabotti expects.
GeneNews Limited, a company focused on developing blood-based biomarker tests for the early detection of diseases and personalized health management, today announced that it has been granted a second U.S. patent for its core platform technology, the Sentinel Principle(R). U.S. Patent # 7,662,558, entitled "Method of profiling gene expression in a human subject."
A major new national report into the use of antiviral drugs (neuraminidase inhibitors) to treat and prevent influenza has drawn heavily on two pieces of research undertaken at The University of Nottingham.
Growth in children is known to be directly affected by two critical factors: food intake and incidence of disease. It is known that access to good quality water, improved sanitation and enhanced hygiene (WASH) practices lead to decreased levels of infectious disease in children. We were interested to know whether this decline in disease would lead to improvements in child growth.
Affymax, Inc. today announced that it has received a $5 million development milestone payment from Takeda Pharmaceutical Company as part of the companies' exclusive global agreement to develop and commercialize Hematide™, Affymax's investigational drug for the treatment of anemia in chronic renal failure patients. The milestone was achieved with the initiation of Phase 3 clinical testing of Hematide to treat anemia in chronic renal failure patients in Japan.
› Verified 6 days ago
| Entity Name | Providence Health & Services Oregon |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023488343 PECOS PAC ID: 0648183608 Enrollment ID: O20031106000652 |
News Archive
Existing techniques for predicting premature birth are inadequate or invasive - with risks and discomfort. Researcher Chiara Rabotti (Eindhoven University of Technology) developed a new measuring method, based on a rather simple electrode plaster that is attached to the abdomen. In the future every pregnant woman can thereby calmly await the moment, Rabotti expects.
GeneNews Limited, a company focused on developing blood-based biomarker tests for the early detection of diseases and personalized health management, today announced that it has been granted a second U.S. patent for its core platform technology, the Sentinel Principle(R). U.S. Patent # 7,662,558, entitled "Method of profiling gene expression in a human subject."
A major new national report into the use of antiviral drugs (neuraminidase inhibitors) to treat and prevent influenza has drawn heavily on two pieces of research undertaken at The University of Nottingham.
Growth in children is known to be directly affected by two critical factors: food intake and incidence of disease. It is known that access to good quality water, improved sanitation and enhanced hygiene (WASH) practices lead to decreased levels of infectious disease in children. We were interested to know whether this decline in disease would lead to improvements in child growth.
Affymax, Inc. today announced that it has received a $5 million development milestone payment from Takeda Pharmaceutical Company as part of the companies' exclusive global agreement to develop and commercialize Hematide™, Affymax's investigational drug for the treatment of anemia in chronic renal failure patients. The milestone was achieved with the initiation of Phase 3 clinical testing of Hematide to treat anemia in chronic renal failure patients in Japan.
› Verified 6 days ago
| Entity Name | Providence Health & Services Oregon |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114015971 PECOS PAC ID: 9335057447 Enrollment ID: O20031117000153 |
News Archive
Existing techniques for predicting premature birth are inadequate or invasive - with risks and discomfort. Researcher Chiara Rabotti (Eindhoven University of Technology) developed a new measuring method, based on a rather simple electrode plaster that is attached to the abdomen. In the future every pregnant woman can thereby calmly await the moment, Rabotti expects.
GeneNews Limited, a company focused on developing blood-based biomarker tests for the early detection of diseases and personalized health management, today announced that it has been granted a second U.S. patent for its core platform technology, the Sentinel Principle(R). U.S. Patent # 7,662,558, entitled "Method of profiling gene expression in a human subject."
A major new national report into the use of antiviral drugs (neuraminidase inhibitors) to treat and prevent influenza has drawn heavily on two pieces of research undertaken at The University of Nottingham.
Growth in children is known to be directly affected by two critical factors: food intake and incidence of disease. It is known that access to good quality water, improved sanitation and enhanced hygiene (WASH) practices lead to decreased levels of infectious disease in children. We were interested to know whether this decline in disease would lead to improvements in child growth.
Affymax, Inc. today announced that it has received a $5 million development milestone payment from Takeda Pharmaceutical Company as part of the companies' exclusive global agreement to develop and commercialize Hematide™, Affymax's investigational drug for the treatment of anemia in chronic renal failure patients. The milestone was achieved with the initiation of Phase 3 clinical testing of Hematide to treat anemia in chronic renal failure patients in Japan.
› Verified 6 days ago
| Entity Name | Oregon Clinic Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265417174 PECOS PAC ID: 2860390408 Enrollment ID: O20031222000096 |
News Archive
Existing techniques for predicting premature birth are inadequate or invasive - with risks and discomfort. Researcher Chiara Rabotti (Eindhoven University of Technology) developed a new measuring method, based on a rather simple electrode plaster that is attached to the abdomen. In the future every pregnant woman can thereby calmly await the moment, Rabotti expects.
GeneNews Limited, a company focused on developing blood-based biomarker tests for the early detection of diseases and personalized health management, today announced that it has been granted a second U.S. patent for its core platform technology, the Sentinel Principle(R). U.S. Patent # 7,662,558, entitled "Method of profiling gene expression in a human subject."
A major new national report into the use of antiviral drugs (neuraminidase inhibitors) to treat and prevent influenza has drawn heavily on two pieces of research undertaken at The University of Nottingham.
Growth in children is known to be directly affected by two critical factors: food intake and incidence of disease. It is known that access to good quality water, improved sanitation and enhanced hygiene (WASH) practices lead to decreased levels of infectious disease in children. We were interested to know whether this decline in disease would lead to improvements in child growth.
Affymax, Inc. today announced that it has received a $5 million development milestone payment from Takeda Pharmaceutical Company as part of the companies' exclusive global agreement to develop and commercialize Hematide™, Affymax's investigational drug for the treatment of anemia in chronic renal failure patients. The milestone was achieved with the initiation of Phase 3 clinical testing of Hematide to treat anemia in chronic renal failure patients in Japan.
› Verified 6 days ago
| Entity Name | Providence Health & Services Oregon |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952482275 PECOS PAC ID: 3072415652 Enrollment ID: O20040123000519 |
News Archive
Existing techniques for predicting premature birth are inadequate or invasive - with risks and discomfort. Researcher Chiara Rabotti (Eindhoven University of Technology) developed a new measuring method, based on a rather simple electrode plaster that is attached to the abdomen. In the future every pregnant woman can thereby calmly await the moment, Rabotti expects.
GeneNews Limited, a company focused on developing blood-based biomarker tests for the early detection of diseases and personalized health management, today announced that it has been granted a second U.S. patent for its core platform technology, the Sentinel Principle(R). U.S. Patent # 7,662,558, entitled "Method of profiling gene expression in a human subject."
A major new national report into the use of antiviral drugs (neuraminidase inhibitors) to treat and prevent influenza has drawn heavily on two pieces of research undertaken at The University of Nottingham.
Growth in children is known to be directly affected by two critical factors: food intake and incidence of disease. It is known that access to good quality water, improved sanitation and enhanced hygiene (WASH) practices lead to decreased levels of infectious disease in children. We were interested to know whether this decline in disease would lead to improvements in child growth.
Affymax, Inc. today announced that it has received a $5 million development milestone payment from Takeda Pharmaceutical Company as part of the companies' exclusive global agreement to develop and commercialize Hematide™, Affymax's investigational drug for the treatment of anemia in chronic renal failure patients. The milestone was achieved with the initiation of Phase 3 clinical testing of Hematide to treat anemia in chronic renal failure patients in Japan.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lianne Liang-jung Lin, MD 541 Ne 20th Ave Ste 225, Portland, OR 97232-2895 Ph: (503) 963-2801 | Lianne Liang-jung Lin, MD 9427 Sw Barnes Rd Ste 296, Portland, OR 97225-6652 Ph: (503) 297-3778 |
News Archive
Existing techniques for predicting premature birth are inadequate or invasive - with risks and discomfort. Researcher Chiara Rabotti (Eindhoven University of Technology) developed a new measuring method, based on a rather simple electrode plaster that is attached to the abdomen. In the future every pregnant woman can thereby calmly await the moment, Rabotti expects.
GeneNews Limited, a company focused on developing blood-based biomarker tests for the early detection of diseases and personalized health management, today announced that it has been granted a second U.S. patent for its core platform technology, the Sentinel Principle(R). U.S. Patent # 7,662,558, entitled "Method of profiling gene expression in a human subject."
A major new national report into the use of antiviral drugs (neuraminidase inhibitors) to treat and prevent influenza has drawn heavily on two pieces of research undertaken at The University of Nottingham.
Growth in children is known to be directly affected by two critical factors: food intake and incidence of disease. It is known that access to good quality water, improved sanitation and enhanced hygiene (WASH) practices lead to decreased levels of infectious disease in children. We were interested to know whether this decline in disease would lead to improvements in child growth.
Affymax, Inc. today announced that it has received a $5 million development milestone payment from Takeda Pharmaceutical Company as part of the companies' exclusive global agreement to develop and commercialize Hematide™, Affymax's investigational drug for the treatment of anemia in chronic renal failure patients. The milestone was achieved with the initiation of Phase 3 clinical testing of Hematide to treat anemia in chronic renal failure patients in Japan.
› Verified 6 days ago
Salona Shrestha, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 4805 Ne Glisan St, Portland, OR 97213 Phone: 503-215-2392 | |
Dr. Emmanuel Trungtoan Tavan, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2800 N Vancouver Ave, Suite 230, Portland, OR 97227 Phone: 503-413-2901 | |
Ginevra Lois Liptan, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 6400 Sw Canyon Ct, Ste 100, Portland, OR 97221 Phone: 503-477-9616 Fax: 503-477-9808 | |
Donald Richard Sullivan, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3181 Sw Sam Jackson Park Rd, Uhn67, Portland, OR 97239 Phone: 503-494-6949 | |
Dr. Victor Nguyen Pham, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 9205 Sw Barnes Rd, Portland, OR 97225 Phone: 503-216-2906 | |
Richa Uppal, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 800 Sw 13th Ave, Portland, OR 97205 Phone: 503-221-0161 Fax: 503-274-1697 | |
Reem Hasan, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3181 Sw Sam Jackson Park Rd, Ppv 350, Portland, OR 97239 Phone: 503-494-8562 |